UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent progress in the diagnosis and treatment of ovarian cancer

CA: a cancer journal for clinicians, 2011-05, Vol.61 (3), p.183-203

2011

Volltextzugriff (PDF)

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Clinical cancer research, 2012-06, Vol.18 (12), p.3462-3469

2012

Volltextzugriff (PDF)

The effect of 1-day multidisciplinary clinic on breast cancer treatment

Breast cancer research and treatment, 2020-08, Vol.182 (3), p.623-629

2020

Volltextzugriff (PDF)

Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells

Proceedings of the National Academy of Sciences - PNAS, 2011-10, Vol.108 (43), p.17773-17778

2011

Volltextzugriff (PDF)

A randomized intervention involving family to improve communication in breast cancer care

NPJ breast cancer, 2021-02, Vol.7 (1), p.14-14, Article 14

2021

Volltextzugriff (PDF)

Role of farletuzumab in epithelial ovarian carcinoma

Current pharmaceutical design, 2012, Vol.18 (25), p.3812-3815

2012

Volltextzugriff (PDF)

Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway Improves Response of Long-term Estrogen-Deprived Breast Cancer Xenografts to Antiestrogens

Clinical cancer research, 2007-05, Vol.13 (9), p.2751-2757

2007

Volltextzugriff (PDF)

The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (9), p.3903-3910

2005

Volltextzugriff (PDF)

Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (11), p.3248-3261

2013

Volltextzugriff (PDF)

Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (12), p.5439-5444

2005

Volltextzugriff (PDF)

The ErbB3-Binding Protein Ebp1 Suppresses Androgen Receptor-Mediated Gene Transcription and Tumorigenesis of Prostate Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (28), p.9890-9895

2005

Volltextzugriff (PDF)

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers

Human pathology, 2014-04, Vol.45 (4), p.880-883

2014

Volltextzugriff (PDF)

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

The Prostate, 2004-03, Vol.58 (4), p.382-393

2004

Volltextzugriff (PDF)

Therapeutic Observations in MCF-7 Aromatase Xenografts

Clinical cancer research, 2005-01, Vol.11 (2), p.884s-888s

2005

Volltextzugriff (PDF)

Docetaxel Followed by Castration Improves Outcomes in LNCaP Prostate Cancer–Bearing Severe Combined Immunodeficient Mice

Clinical cancer research, 2006-01, Vol.12 (1), p.169-174

2006

Volltextzugriff (PDF)

Abstract P1-23-02: Incidence, clinicopathological features and treatment patterns of male breast cancer (MBC) in a high-volume cancer center in the United Arab Emirates (UAE)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-23-02

2022

Volltextzugriff (PDF)

Treatment of HER2-positive breast cancer

Breast (Edinburgh), 2014-04, Vol.23 (2), p.128-136

2014

Volltextzugriff (PDF)

Prevalence of chemopreventive agent use among hospitalized women at high risk for breast cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e13050-e13050

2016

Volltextzugriff (PDF)

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Clinical cancer research, 2014-05, Vol.20 (10), p.2643-2650

2014

Volltextzugriff (PDF)

PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells

Cancer biology & therapy, 2011-02, Vol.11 (3), p.358-367

2011

Volltextzugriff (PDF)

HER2-directed therapy for metastatic breast cancer

Oncology (Williston Park, N.Y.), 2013-03, Vol.27 (3), p.166-175

2013

Volltextzugriff (PDF)

Effects of Exemestane and Tamoxifen in a Postmenopausal Breast Cancer Model

Clinical cancer research, 2004-11, Vol.10 (21), p.7375-7381

2004

Volltextzugriff (PDF)

PTEN promoter silencing and Cowden syndrome: the role of epigenetic regulation of KILLIN

JAMA : the journal of the American Medical Association, 2010-12, Vol.304 (24), p.2744

2010

Volltextzugriff (PDF)

Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study

BMJ open, 2016-11, Vol.6 (11), p.e012550-e012550

2016

Volltextzugriff (PDF)

A clinical study of tremelimumab alone or in combination with olaparib in patients with advanced epithelial ovarian cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6045-6045

2020

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Female
(28)
Oncology
(24)
Biological And Medical Sciences
(18)
Mice
(17)
Animals
(16)
Medical Sciences
(14)
Breast Cancer
(13)
Breast Neoplasms - Drug Therapy
(13)
Tumors
(13)
Antineoplastic Agents
(12)
Pharmacology. Drug Treatments
(12)
Cell Line, Tumor
(11)
Mice, Nude
(9)
Mice, Inbred Balb C
(8)
Aged
(7)
Antineoplastic Agents - Therapeutic Use
(7)
Aromatase Inhibitors
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent progress in the diagnosis and treatment of ovarian cancer

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

The effect of 1-day multidisciplinary clinic on breast cancer treatment

Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells

A randomized intervention involving family to improve communication in breast cancer care

Role of farletuzumab in epithelial ovarian carcinoma

Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway Improves Response of Long-term Estrogen-Deprived Breast Cancer Xenografts to Antiestrogens

The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation

Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation

Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model

The ErbB3-Binding Protein Ebp1 Suppresses Androgen Receptor-Mediated Gene Transcription and Tumorigenesis of Prostate Cancer Cells

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

Therapeutic Observations in MCF-7 Aromatase Xenografts

Docetaxel Followed by Castration Improves Outcomes in LNCaP Prostate Cancer–Bearing Severe Combined Immunodeficient Mice

Abstract P1-23-02: Incidence, clinicopathological features and treatment patterns of male breast cancer (MBC) in a high-volume cancer center in the United Arab Emirates (UAE)

Treatment of HER2-positive breast cancer

Prevalence of chemopreventive agent use among hospitalized women at high risk for breast cancer

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells

HER2-directed therapy for metastatic breast cancer

Effects of Exemestane and Tamoxifen in a Postmenopausal Breast Cancer Model

PTEN promoter silencing and Cowden syndrome: the role of epigenetic regulation of KILLIN

Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study

A clinical study of tremelimumab alone or in combination with olaparib in patients with advanced epithelial ovarian cancer

Suchergebnisse filtern